JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors
- 30 May 2019
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (25) , 12442-12451
Abstract
Tumor-associated macrophages contribute to tumor progression and therapeutic resistance in breast cancer. Within the tumor microenvironment, tumor-derived factors activate pathways that modulate macrophage function. Using in vitro and in vivo models, we find that tumor-derived factors induce activation of the Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathway in macrophages. We also demonstrate that loss of STAT3 in myeloid cells leads to enhanced mammary tumorigenesis. Further studies show that macrophages contribute to resistance of mammary tumors to the JAK/STAT inhibitor ruxolitinib in vivo and that ruxolitinib-treated macrophages produce soluble factors that promote resistance of tumor cells to JAK inhibition in vitro. Finally, we demonstrate that STAT3 deletion and JAK/STAT inhibition in macrophages increases expression of the protumorigenic factor cyclooxygenase-2 (COX-2), and that COX-2 inhibition enhances responsiveness of tumors to ruxolitinib. These findings define a mechanism through which macrophages promote therapeutic resistance and highlight the importance of understanding the impact of targeted therapies on the tumor microenvironment.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (F31CA220746)
- HHS | NIH | National Cancer Institute (T32CA009138)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (T32AI007313)
- HHS | NIH | National Cancer Institute (R01CA215052)
- U.S. Department of War (W81XWH-16-1-0034)
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD095858)
This publication has 73 references indexed in Scilit:
- PGE2/EP4 antagonism enhances tumor chemosensitivity by inducing extracellular vesicle‐mediated clearance of cancer stem cellsInternational Journal of Cancer, 2018
- Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer modelsNature Communications, 2016
- G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancerOncoImmunology, 2015
- MyeloidSTAT3promotes formation of colitis-associated colorectal cancer in miceOncoImmunology, 2015
- Revisiting STAT3 signalling in cancer: new and unexpected biological functionsNature Reviews Cancer, 2014
- Macrophage Activation and Polarization: Nomenclature and Experimental GuidelinesImmunity, 2014
- Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor FormationCancer Research, 2014
- JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast CancerCancer Cell, 2012
- A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated TumorigenesisThe American Journal of Pathology, 2010
- Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerBreast Cancer Research, 2007